Author:
Editor(s):
Updated:
ULY CLINIC
ULY CLINIC
9 Septemba 2025, 05:23:25
Erythema
Erythema, characterized by dilated or congested blood vessels resulting in red, scaly skin, is the most common sign of skin inflammation or irritation. It may present as localized or generalized, sudden or gradual, and its color can range from bright red in acute conditions to violet or brown in chronic cases. Differentiation from purpura is critical: erythema blanches under pressure, whereas purpura does not.
Pathophysiology
Erythema primarily results from increased perfusion in the dermal small vessels. Mechanisms include drug reactions, neurogenic changes, trauma, tissue damage, or disorders affecting vascular support structures. Rare causes include acute febrile neutrophilic dermatosis, erythema ab igne, erythema chronicum migrans, erythema gyratum repens, and toxic epidermal necrolysis.
Clinical Assessment
History Taking:
Onset, duration, and progression of erythema
Associated symptoms: pain, itching, fever, malaise, joint pain
Recent infections, trauma, or drug exposure
Family history of skin disorders or allergic conditions
Exposure to chemicals, UV light, or infectious contacts
Physical Examination:
Distribution, extent, and intensity of erythema
Presence of hair loss, edema, or secondary skin lesions (hives, scales, vesicles, purpura)
Palpation for warmth, tenderness, or crepitus
Special attention to skin changes in darker-skinned patients, which may appear bluish or purple
Medical Causes
Table 1: Causes of Erythema – Distinguishing Features and Key Clinical Information
Cause | Clinical Features / Distinguishing Signs | Distribution / Pattern | Other Key Information / Considerations |
Allergic Reactions / Anaphylaxis | Sudden erythema, urticaria, flushing, facial edema, diaphoresis, hypotension, airway compromise | Generalized; may involve face and trunk | Life-threatening if anaphylaxis; requires epinephrine, airway management |
Burns (Thermal / UV) | Redness, swelling, tenderness, possible blisters; delayed erythema for sunburn | Exposed skin areas | Assess burn depth; manage pain, fluids, infection risk |
Candidiasis (Intertrigo) | Erythema with satellite pustules, scaly papular rash | Skin folds: axillae, under breasts, groin, neck, umbilicus | Common in immunocompromised or diabetic patients |
Cellulitis | Red, warm, tender, swollen skin; may have systemic signs (fever) | Localized, often unilateral | Bacterial infection; risk of sepsis; treat with antibiotics |
Atopic Dermatitis | Erythema with pruritus, small papules, scaling, lichenification | Flexural areas: neck, antecubital, popliteal fossa | Chronic, recurrent; may precede secondary infections |
Contact Dermatitis | Acute erythema, vesicles, blisters, or ulceration after exposure | Exposed areas corresponding to irritant | Identify and remove trigger; topical steroids often required |
Seborrheic Dermatitis | Dull red or yellow erythema with greasy scales | Scalp, eyebrows, nasolabial folds, chest; butterfly rash on face possible | Common in HIV patients and infants (cradle cap) |
Dermatomyositis | Dusky lilac rash, Gottron’s papules over joints, heliotrope rash on eyelids | Face, neck, upper torso, nail beds | Associated with muscle weakness; often autoimmune; may require systemic steroids |
Erythema Multiforme Minor | Target-like lesions, urticarial, minimal mucosal involvement | Flexor surfaces of extremities; crops | Often post-infection (HSV, Mycoplasma); self-limited |
Erythema Multiforme Major / Stevens-Johnson Syndrome | Widespread symmetrical bullous lesions, mucosal erosions, fever, malaise | Generalized, often trunk and extremities | Drug reaction common; life-threatening; manage like severe burn |
Erythema Nodosum | Tender, firm nodules; may be accompanied by fever, malaise, joint pain | Bilateral shins, sometimes knees, ankles, arms, buttocks | Associated with IBD, sarcoidosis, infections (strep, TB); self-limited or treat underlying cause |
Gout | Tight, erythematous skin over inflamed joint | Usually first MTP joint, knees, elbows | Acute monoarthritis; treat with NSAIDs, colchicine |
Lupus Erythematosus | Butterfly rash, photosensitivity, telangiectasia, purpura, mucosal ulcers | Face, sun-exposed areas | Systemic symptoms possible (fever, fatigue, arthralgia); autoimmune management |
Psoriasis | Silvery-white scales over erythematous plaques, pitting nails | Elbows, knees, scalp, chest, intergluteal folds | Chronic, recurrent; systemic therapy if extensive |
Rosacea | Central facial erythema, telangiectasia, papules, pustules; rhinophyma possible | Nose, cheeks, forehead, chin | Chronic, may be triggered by alcohol, heat, sun |
Radiation / Drug-Induced | Dull erythema, edema; may be symmetric; timing related to exposure | Localized or generalized | Assess drug history; may require discontinuation and supportive care |
Neonatal / Pediatric Rashes | Erythema toxicum neonatorum: pink papular rash, resolves spontaneously; Roseola, rubella: erythematous maculopapular rashes with fever | Trunk, extremities, face | Consider infectious causes; hospitalization if neonate has fever |
Actinic Purpura (Elderly) | Well-demarcated purple macules or patches, mainly dorsal hands and forearms | Hands, forearms | Result of fragile capillaries; usually self-limited |
Notes for Healthcare Professionals:
Always assess systemic signs such as fever, hypotension, dyspnea, and mucosal involvement.
Pediatric and geriatric patients may present differently; consider developmental and skin aging factors.
Rapid identification of life-threatening causes (anaphylaxis, SJS, severe burns) is critical.
Document drug history, exposures, and underlying diseases to guide management.
Emergency interventions and supportive care
Table 2: Emergency Interventions & Supportive Care for Erythema
Cause / Condition | Emergency Interventions | Supportive Care / Monitoring |
Anaphylaxis / Severe Allergic Reaction | Immediate epinephrine IM; maintain airway; supplemental oxygen; IV fluids for hypotension | Monitor vitals, respiratory status, and mental status; antihistamines and corticosteroids as adjuncts |
Severe Burns (Thermal / UV) | Stop burning process; assess airway if inhalation injury suspected | Cool affected area; analgesics; fluid replacement; monitor for infection and shock |
Erythema Multiforme Major / SJS | Hospitalization; discontinue offending drug; supportive care similar to burn management | Fluid and electrolyte replacement; wound care; pain control; monitor for secondary infection |
Cellulitis | Assess for sepsis; hemodynamic support if hypotensive | IV or oral antibiotics; monitor for progression, fever, systemic symptoms |
Erythema Nodosum | Rule out systemic infection; supportive only unless underlying cause severe | NSAIDs for pain and inflammation; elevate affected limbs; treat underlying disease |
Gout with Erythema | NSAIDs or colchicine for acute flare | Rest joint; apply ice; educate on diet and medications to prevent recurrence |
Severe Lupus Erythematosus Flare | Hospitalization if systemic involvement; corticosteroids or immunosuppressants | Monitor renal, hematologic, and cardiac function; supportive skin care; avoid sun exposure |
Neonatal / Pediatric Erythema with Fever | Assess airway, breathing, circulation; admit if sepsis suspected | Hydration; treat underlying infection; monitor vitals and perfusion |
Drug-Induced Erythema | Discontinue offending agent; treat anaphylaxis if present | Symptomatic relief with antihistamines, topical corticosteroids; monitor for systemic reaction |
Radiation-Induced Erythema | Usually non-emergent unless widespread skin breakdown | Topical emollients, corticosteroids; avoid further exposure; monitor for infection |
Special Considerations
Monitor fluid and electrolyte balance in patients with extensive erythema or burns.
Withhold potential causative medications until the etiology is identified.
Consider topical or systemic corticosteroids and antibiotics as clinically indicated.
Diagnostic Workup
Skin biopsy for atypical lesions or suspected malignancy
Culture and sensitivity for infectious causes
Laboratory studies for systemic involvement: CBC, inflammatory markers, autoantibodies
Patient Counseling
Educate patients to recognize early signs of flare-ups.
Advise sun protection and avoidance of triggering substances.
Recommend skin care strategies: soothing baths, wet dressings, antihistamines, and analgesics.
Pediatric Considerations
Neonatal erythema (toxicum neonatorum) is self-limited.
Infants may develop erythema from infections, candidiasis, or dermatologic conditions.
Hospitalization may be warranted for neonates with fever and erythema.
Geriatric Considerations
Elderly patients often present with actinic purpura: well-demarcated purple macules on the hands and forearms.
Lesions usually resolve spontaneously.
References:
Jeon HC, Choi M, Paik SH, Paik SH, Na SJ, Lee JH, Cho S. A case of assisted reproductive therapy-induced erythema nodosum. Ann Dermatol. 2010;23(3):362–364.
Papagrigoraki A, Gisondi P, Rosina P, Cannone M, Girolomoni A. Erythema nodosum: Etiological factors and relapses in a retrospective cohort study. Eur J Dermatol. 2010;20(6):773–777.
Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 6th ed. Philadelphia: Elsevier; 2015.
James WD, Berger TG, Elston DM. Andrews' Diseases of the Skin: Clinical Dermatology. 13th ed. Philadelphia: Elsevier; 2019.
Bolognia JL, Schaffer JV, Cerroni L. Dermatology. 4th ed. London: Elsevier; 2018.
Tüzün Y, Wolf R. Erythema: Clinical manifestations and pathophysiology. Clin Dermatol. 2012;30(1):3–15.
Heng MCY, Heng MK. Drug-induced erythema and dermatologic adverse reactions. Dermatol Ther. 2010;23(4):372–383.
Haberman HF. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Dermatol Clin. 2011;29(2):231–240.
Schwartz RA, Nervi SJ. Erythema nodosum: A sign of systemic disease. J Am Acad Dermatol. 2007;57(2):241–253.
Weston WL, Morelli JG. Pediatric dermatology: Neonatal erythema and rashes in infants. Pediatr Clin North Am. 2006;53(3):503–519.
